-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Quest Diagnostics, Raises Price Target to $192

Benzinga·07/23/2025 14:57:22
Listen to the news
Truist Securities analyst David Macdonald maintains Quest Diagnostics (NYSE:DGX) with a Hold and raises the price target from $190 to $192.